Eva Petrovova | Biomedicine | Innovative Research Award

Published on by Cognitive Scientist Awards

Innovative Research Award

Eva Petrovova
University of Veterinary Medicine and Pharmacy in Kosice

Eva Petrovova
Affiliation University of Veterinary Medicine and Pharmacy in Kosice
Country Slovakia
Scopus ID 23985476400
Documnts 69
Citatios 930
h-index 18
Subject Area Biomedicine
Event International Cognitive Scientist Awards
ORCID 0000-0002-9141-4211

Eva Petrovova is affiliated with the University of Veterinary Medicine and Pharmacy in Kosice, Slovakia. Her academic profile is presented in connection with the Innovative Research Award at the International Cognitive Scientist Awards. The supplied bibliometric data records 69 documents, 930 citations and an h-index of 18 in biomedicine. These indicators offer a quantitative overview of indexed scholarly output and citation activity. A balanced assessment should also consider the originality, rigor, relevance and potential impact of individual research contributions. [1]

Abstract

This article outlines Eva Petrovova’s academic profile using the supplied institutional affiliation and bibliometric information. Her publication and citation indicators provide a quantitative perspective on scholarly activity in biomedicine. Further evaluation should examine research quality, methodological rigor, originality and scientific significance. [1]

Keywords

Eva Petrovova; biomedicine; scientific research; academic publications; citation impact; research evaluation; Slovakia; Innovative Research Award.

Introduction

Academic recognition can highlight research achievements and encourage continued scientific inquiry. Bibliometric indicators help describe publication productivity and citation patterns, but they do not independently establish the quality or significance of every contribution. The available profile provides a starting point for documenting Petrovova’s academic record and evaluating it within an award context. [2]

Research Profile

Petrovova is affiliated with the University of Veterinary Medicine and Pharmacy in Kosice, Slovakia. Her stated subject area is biomedicine, encompassing scientific investigation of biological processes and health-related questions. Her Scopus identifier links to an indexed author record, while her ORCID provides a persistent researcher identifier. Specific research specializations should be established through verified publications rather than inferred from affiliation alone. [1]

Research Contributions

The supplied metrics document indexed scholarly output and recorded citations. A detailed assessment of research contributions requires examination of published studies, research questions, methods, findings and subsequent applications. Specific discoveries or clinical outcomes should only be attributed when supported by verified research publications.

Publications

The supplied Scopus information records 69 documents. Individual publication titles, journal details, publication dates and DOIs were not provided. Readers can consult the linked author profile to review indexed publications and verify bibliographic details. No specific publication DOI is listed because none was supplied.

Research Impact

The reported 930 citations indicate scholarly references to the indexed documents, while an h-index of 18 combines publication productivity with citation frequency. These values can change as databases are updated and may differ across platforms. They should be interpreted alongside research quality, field-specific citation practices and the influence of individual studies. [2]

Award Suitability

The Innovative Research Award provides a context for evaluating scientific work in terms of originality, rigor and potential contribution. Petrovova’s supplied bibliometric profile offers quantitative information for consideration by the award committee. A complete assessment should also consider verified publications, evidence of innovation, research significance and the award’s official evaluation criteria. This profile does not independently confirm an award decision.

Conclusion

Eva Petrovova’s profile records an academic affiliation in Slovakia, a subject area of biomedicine, 69 documents, 930 citations and an h-index of 18. These indicators summarize aspects of indexed scholarly activity but do not replace qualitative evaluation. Verification of her publications and research contributions would support a balanced assessment for the Innovative Research Award at the International Cognitive Scientist Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Eva Petrovova, Author ID 23985476400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23985476400
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102

 

Serife Emre Ünsal | Medicine | Innovative Research Award

Published on by Cognitive Scientist Awards

Innovative Research Award

Serife Emre Ünsal
Erciyes University

Serife Emre Ünsal
Affiliation Erciyes University
Country Turkey
Scopus ID 60178187600
Documents 2
Subject Area Medicine
Event International Cognitive Scientist Awards
ORCID 0000-0003-4581-8722

Serife Emre Ünsal is affiliated with Erciyes University in Turkey and is identified in the subject area of medicine. This academic profile presents the available researcher information in connection with the Innovative Research Award at the International Cognitive Scientist Awards. It provides a structured overview of the researcher’s affiliation, scholarly identifiers, and potential recognition context without making unsupported claims about specific publications or research findings.[1]

Abstract

This profile introduces Serife Emre Ünsal, a researcher associated with Erciyes University in Turkey, in the field of medicine. It organizes the supplied academic identification details for consideration in connection with the Innovative Research Award. The profile highlights the importance of scientific inquiry, research integrity, and evidence-based contributions to medical knowledge. A comprehensive evaluation of individual achievements should be supported by verified publications and documented research outcomes.[1]

Keywords

Medicine; medical research; scientific innovation; academic scholarship; research evaluation; Erciyes University; Turkey; research recognition; Innovative Research Award.

Introduction

Medical research advances understanding of health, disease, diagnosis, and treatment. Recognizing researchers requires careful consideration of the originality, reliability, relevance, and potential value of their work. This article provides a concise academic overview of the supplied information about Serife Emre Ünsal and establishes a framework for presenting her research profile. Further assessment should rely on verifiable scholarly evidence and documented contributions.[2]

Research Profile

The supplied information identifies Serife Emre Ünsal with Erciyes University in Turkey and lists medicine as her subject area. Her Scopus author profile and ORCID record provide reference points for verifying scholarly identity and associated research information. These identifiers help organize academic records and support accurate attribution. No specific medical specialization or institutional position is assumed beyond the details provided.[1]

Research Contributions

Medical research may contribute through clinical investigation, improved research methods, evidence synthesis, diagnostic development, and findings relevant to healthcare practice. The value of any contribution depends on methodological rigor, reproducibility, ethical conduct, and relevance to existing scientific knowledge. Evaluating this researcher’s contributions therefore requires examination of verified studies, their findings, and their potential implications rather than assumptions based on affiliation alone.

Publications

The supplied profile reports two documents associated with the researcher record. Individual publication titles, journal details, publication dates, and DOIs were not supplied and are therefore not listed here. The Scopus author profile can be consulted to verify bibliographic records and determine the nature of the research represented in the database.[1]

Research Impact

Research impact should be considered through multiple dimensions, including publication quality, scientific rigor, reproducibility, contribution to knowledge, and potential relevance to medical practice. Bibliographic information can help establish the existence of scholarly work, but it cannot independently demonstrate clinical benefit or scientific significance. A balanced evaluation should consider the context, limitations, and documented outcomes of each contribution.[2]

Award Suitability

The Innovative Research Award, presented within the International Cognitive Scientist Awards framework, offers a context for recognizing research-related achievements. The candidate’s stated affiliation and medical subject area provide a starting point for academic evaluation. A fair assessment should examine originality, supporting publications, research integrity, and evidence of meaningful scientific contributions. This profile presents the supplied information and does not imply confirmation of a final award decision.

Conclusion

Serife Emre Ünsal is identified in the supplied information as a researcher affiliated with Erciyes University in Turkey, working in the subject area of medicine. Her linked Scopus and ORCID records provide starting points for verifying academic information. Further review of publications and documented findings would support a more detailed assessment of her research contributions and suitability for the Innovative Research Award.

References

  1. Elsevier. (n.d.). Scopus author details: Serife Emre Ünsal, Author ID 60178187600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60178187600
  2. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.icmje.org/recommendations/
  3. ORCID. (n.d.). ORCID record: Serife Emre Ünsal.
    https://orcid.org/0000-0003-4581-8722

 

Klaus Liefeith | Medicine and Dentistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Best Researcher Award

Klaus Liefeith
Researcher Klaus Liefeith
Affiliation Institute for Bioprocessing and Analytical Measurement Techniques e.V.
Country Germany
Scopus ID 6602970287
Documents 95
Citations 1811
h-index 21
Subject Area Medicine and Dentistry
Event International Cognitive Scientists Award
ORCID 0000-0002-8122-4481

Klaus Liefeith
Institute for Bioprocessing and Analytical Measurement Techniques e.V.

Klaus Liefeith is a German researcher affiliated with the Institute for Bioprocessing and Analytical Measurement Techniques e.V. and is recognized for his scientific contributions within the fields of biomaterials, regenerative medicine, tissue engineering, and biomedical technologies. His scholarly work has contributed to the advancement of translational medical research, particularly through the development of innovative materials and analytical approaches designed to support healthcare applications. Based on publication records indexed in Scopus, his research output demonstrates sustained academic productivity and measurable scholarly influence through citations and collaborative scientific engagement.[1]

Abstract

This article presents an academic overview of Klaus Liefeith and his research achievements in the areas of biomaterials, biomedical engineering, regenerative medicine, and applied medical sciences. Through a documented publication record consisting of 95 indexed documents and more than 1,800 citations, Liefeith has contributed to scientific understanding in areas associated with tissue regeneration, medical devices, biofunctional materials, and analytical measurement technologies. His research portfolio reflects interdisciplinary collaboration and sustained scholarly activity that supports innovation in healthcare and medical research.[1]

Keywords

Biomaterials, Regenerative Medicine, Tissue Engineering, Biomedical Engineering, Medical Devices, Analytical Measurement Techniques, Translational Research, Medicine and Dentistry, Research Impact, Scientific Innovation.

Introduction

The advancement of modern healthcare increasingly depends on interdisciplinary scientific research that combines biological sciences, engineering principles, and material innovations. Researchers operating at the interface of these disciplines play a significant role in developing technologies that improve diagnostic, therapeutic, and regenerative medical practices. His research activities are associated with the translation of laboratory discoveries into practical healthcare solutions, contributing to broader scientific progress in medicine and dentistry.[2]

Research Profile

Liefeith’s professional profile demonstrates sustained involvement in applied biomedical research. Working within the Institute for Bioprocessing and Analytical Measurement Techniques e.V., His work reflects an interdisciplinary approach that integrates engineering concepts with biological systems to address contemporary healthcare challenges. The diversity of his publication record illustrates active participation in international scientific discussions and collaborative research networks.[1]

Research Contributions

  • Development and characterization of biomaterials suitable for biomedical and regenerative applications.
  • Research on tissue engineering scaffolds designed to support cellular growth and tissue regeneration.
  • Contributions to analytical measurement techniques relevant to biological and medical investigations.
  • Investigation of biofunctional surfaces intended to improve interactions between materials and biological systems.
  • Participation in collaborative studies supporting translational medicine and healthcare innovation.[3]

Publications

According to available indexing databases, Klaus Liefeith has authored and co-authored numerous peer-reviewed publications across biomedical and materials science disciplines. His publication record includes articles examining biomaterials, tissue engineering constructs, regenerative therapies, analytical technologies, and biomedical surface modifications. These publications have been disseminated through international scientific journals and conference proceedings, facilitating knowledge exchange within the global research community.[1]

Research Impact

Research impact may be assessed through scholarly indicators including publication volume, citation frequency, and h-index performance. With 95 indexed documents, 1,811 citations, and an h-index of 21, Liefeith’s academic record demonstrates sustained visibility within the scientific literature. These indicators suggest that his work has been referenced by researchers across multiple disciplines and continues to contribute to ongoing scientific investigations. Citation activity further reflects the relevance of his research outputs to current developments in biomedical science and healthcare innovation.[1]

Award Suitability

The Best Researcher Award recognizes sustained scientific excellence, impactful scholarship, and meaningful contributions to academic advancement. Klaus Liefeith’s publication portfolio, citation record, interdisciplinary research engagement, and contributions to biomedical innovation align with several criteria commonly associated with distinguished research recognition. His work demonstrates continued commitment to scientific inquiry and practical healthcare applications, supporting the objectives of the International Cognitive Scientists Award program.[1][4]

Conclusion

Klaus Liefeith represents an established contributor to biomedical and regenerative medicine research. Through extensive scholarly activity, interdisciplinary collaboration, and the development of innovative biomaterial solutions, he has participated in advancing scientific knowledge relevant to healthcare and medical technology. His documented publication and citation record, together with his contributions to translational biomedical research, provide a foundation supporting recognition within the Best Researcher Award category. Continued engagement in scientific investigation is expected to further contribute to the evolution of biomedical sciences and related healthcare applications.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Klaus Liefeith, Author ID 6602970287. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602970287
  2. ORCID. (n.d.). Klaus Liefeith Research Profile.
    https://orcid.org/0000-0002-8122-4481
  3. Liefeith, K. et al. Research in biomaterials and regenerative medicine.
    DOI: https://doi.org/10.1016/j.actbio.2012.07.017
  4. International Cognitive Scientists Award. (n.d.). Award Information and Recognition Criteria.
    https://cognitivescientist.org/

Md Jannatul Islam Polash | Drug Design | Research Excellence Award

Published on by Cognitive Scientist Awards

Mr. Md Jannatul Islam Polash | Drug Design | Research Excellence Award

Islamic University | Bangladesh

Mr. Md Jannatul Islam Polash is an emerging pharmaceutical researcher specializing in antibiotic resistance, antidiabetic drug discovery, phytochemical analysis, and bioinformatics. His work integrates in vitro, in vivo, and in silico approaches, with publications in high-impact journals including Biomedicine & Pharmacotherapy, Scientific Reports, and Journal of Cellular and Molecular Medicine. He has contributed to systematic reviews, molecular docking studies, and multimodal pharmacological evaluations, reflecting strong interdisciplinary research capacity. His scholarly profile shows Citations: 16, h-index: 2, i10-index: 1, indicating growing academic impact and promise in translational pharmaceutical sciences.

Citation Metrics (Google Scholar)

20

15

10

5

0

Citations 16

Documents 7

h-index
2

Citations
Documents
h-index


View Google Scholar Profile

Featured Publications

Joanna Bartkowiak-Wieczorek | pharmacogenetics | Best Researcher Award

Published on by Cognitive Scientist Awards

 Dr. Joanna Bartkowiak-Wieczorek | pharmacogenetics | Best Researcher Award 🏆

Physiology Department at Poznan University of Medical Sciences🎓

Dr. Joanna Bartkowiak-Wieczorek is a distinguished pharmacogeneticist and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań. She holds a Master’s in Biological Sciences from Adam Mickiewicz University, where she first explored molecular biology, and earned her Ph.D. at the Medical University of Poznań, focusing on genetic markers related to osteoporosis. With expertise in pharmacogenetics, biochemistry, and molecular biology, Dr. Bartkowiak-Wieczorek’s research examines gene-drug interactions and plant-based compounds, particularly cannabinoids in oncology. A committed educator, she teaches pharmacology and quality management, instilling rigorous standards in future healthcare professionals. Her work in personalized medicine and dedication to research quality has garnered significant recognition and establishes her as a leading figure in pharmacogenetics.

 

Professional Profile 

Education 🎓:

Dr. Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University, Poznań, where she specialized in molecular biology, conducting research on modified DNA bases. She earned her Ph.D. from the Medical University of Poznań and Adam Mickiewicz University, focusing on genetic polymorphisms related to osteoporosis risk. Her doctoral work on estrogen and calcitonin receptors laid the foundation for her expertise in pharmacogenetics.

Work Experience 💼:

Dr. Bartkowiak-Wieczorek is currently an Assistant Professor and research staff member at the Medical University of Karol Marcinkowski in Poznań, where she has been teaching and conducting research since 2018. Previously, she worked at the Medical University of Poznań, focusing on pharmacogenetics research and quality management in drug development. She also contributed to the Institute of Natural Fibres and Medicinal Plants, Poznań, implementing ISO and GMP standards, which supports her commitment to rigorous quality in research and clinical practices.

Skills 🔍

Dr. Bartkowiak-Wieczorek is skilled in pharmacogenetic analysis, biochemistry, and molecular biology techniques, including DNA isolation, PCR, and ELISA. She has a strong foundation in quality management, having implemented GMP, ISO 9001, and ISO 17025 standards in clinical and preclinical studies. Her expertise also extends to pharmacogenetic testing, pharmacotherapy, and plant-based compound analysis, notably with cannabinoids.

Awards and Honors 🏆

Dr. Bartkowiak-Wieczorek is skilled in pharmacogenetic analysis, biochemistry, and molecular biology techniques, including DNA isolation, PCR, and ELISA. She has a strong foundation in quality management, having implemented GMP, ISO 9001, and ISO 17025 standards in clinical and preclinical studies. Her expertise also extends to pharmacogenetic testing, pharmacotherapy, and plant-based compound analysis, notably with cannabinoids.

🤝 Memberships:

Dr. Bartkowiak-Wieczorek is actively involved in several scientific communities, contributing her knowledge in biochemistry, pharmacology, and personalized medicine. Her collaborative work with institutions such as the National Science Centre and participation in interdisciplinary research projects demonstrate her dedication to advancing pharmacogenetics and biopharmacy.

Teaching Experience 👩‍🏫:

She has extensive teaching experience, instructing students in various programs, including Medicine, Pharmacy, and Dentistry, at the Medical University of Karol Marcinkowski. Her courses cover human physiology, pharmacology, pharmacogenetics, and quality management, reflecting her comprehensive approach to teaching future medical professionals.

Research Focus 🔬:

Dr. Bartkowiak-Wieczorek’s research centers on pharmacogenetics, particularly the interaction of genetics with drug efficacy and safety. She explores plant-based compounds, with a specific focus on cannabinoids and their applications in oncology and chronic disease management. Her research projects include studies on gene expression, drug interactions, and the pharmacokinetics of pediatric treatments, which contribute to the field of personalized medicine.

Conclusion 

Dr. Joanna Bartkowiak-Wieczorek is a highly deserving candidate for the Best Researcher Award. Her pioneering work in pharmacogenetics, coupled with her dedication to research quality, personalized medicine, and plant-based medicinal compounds, underscores her profound impact on modern pharmacology. Expanding her research outreach and international collaborations could further amplify her contributions, solidifying her role as a leader in personalized medicine.

📚 Publilcation 

  • Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat
    2024, Biomolecules, 14(9), 1065
  • Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi Is a Promising Candidate for the Treatment of Cancer, Alzheimer’s Disease, and Obesity
    2024, Nutrients, 16(15), 2509
  • The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on the Physiological and Pathophysiological Functions of Tissues and Organs
    2024, International Journal of Molecular Sciences, 25(15), 8167
  • Natural Products and Health
    2024, Nutrients, 16(3), 415
  • THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?
    2023, Nutrients, 15(12), 2646
  • Krytyczne spojrzenie na nowe możliwości zastosowania terapeutycznego statyn – podsumowanie aktualnego stanu wiedzy
    2023, Farmacja Polska, 79(5), 297-315
  • The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia—A Narrative Review
    2022, Nutrients, 14(17), 3478
  • High-fat, Western-style diet, systemic inflammation, and gut microbiota: A narrative review
    2021, Cells, 10(11), 3164
  • The Effect of Genetic Variations for Interleukin-10 (IL-10) on the Efficacy of Immunosuppressive Therapy in Patients after Kidney Transplantation
    2020, International Immunopharmacology, 89, 107059
  • The Effect of Different Water Extracts from Platycodon grandiflorum on Selected Factors Associated with Pathogenesis of Chronic Bronchitis in Rats
    2020, Molecules (Basel, Switzerland), 25(21)B